ATE470452T1 - Impfstoff enthaltend lactobacilli zur behandlung von entzündungen der prostata und gutartigen prostata-hyperplasien - Google Patents

Impfstoff enthaltend lactobacilli zur behandlung von entzündungen der prostata und gutartigen prostata-hyperplasien

Info

Publication number
ATE470452T1
ATE470452T1 AT00981507T AT00981507T ATE470452T1 AT E470452 T1 ATE470452 T1 AT E470452T1 AT 00981507 T AT00981507 T AT 00981507T AT 00981507 T AT00981507 T AT 00981507T AT E470452 T1 ATE470452 T1 AT E470452T1
Authority
AT
Austria
Prior art keywords
prostate
inflammation
treatment
vaccine containing
benign
Prior art date
Application number
AT00981507T
Other languages
English (en)
Inventor
Gyula Varga
Erika Lazar
Jozsef Bartus
Karoly Ujhelyi
Original Assignee
Vakcina Kft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vakcina Kft filed Critical Vakcina Kft
Application granted granted Critical
Publication of ATE470452T1 publication Critical patent/ATE470452T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT00981507T 1999-11-25 2000-11-23 Impfstoff enthaltend lactobacilli zur behandlung von entzündungen der prostata und gutartigen prostata-hyperplasien ATE470452T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU9904408A HU227086B1 (en) 1999-11-25 1999-11-25 Lactobacillus vaccine for treating prostata inflammatory and benign prostata hyperplasia
PCT/HU2000/000122 WO2001037862A2 (en) 1999-11-25 2000-11-23 A vaccine comprising lactobacilli for treating prostate inflammation and benign prostate hyperplasias

Publications (1)

Publication Number Publication Date
ATE470452T1 true ATE470452T1 (de) 2010-06-15

Family

ID=90014600

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00981507T ATE470452T1 (de) 1999-11-25 2000-11-23 Impfstoff enthaltend lactobacilli zur behandlung von entzündungen der prostata und gutartigen prostata-hyperplasien

Country Status (20)

Country Link
US (4) US20080175865A1 (de)
EP (1) EP1272216B1 (de)
AT (1) ATE470452T1 (de)
AU (1) AU779214B2 (de)
CA (1) CA2394843C (de)
CZ (1) CZ302662B6 (de)
DE (1) DE60044539D1 (de)
DK (1) DK1272216T3 (de)
EA (1) EA005198B1 (de)
ES (1) ES2348591T3 (de)
HU (1) HU227086B1 (de)
IL (2) IL149779A0 (de)
PL (1) PL201804B1 (de)
PT (1) PT1272216E (de)
RO (1) RO122760B1 (de)
RS (1) RS51201B (de)
SI (1) SI20960B (de)
SK (1) SK288132B6 (de)
UA (1) UA78673C2 (de)
WO (1) WO2001037862A2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1723965A1 (de) 2005-05-18 2006-11-22 Stallergenes Sa Zusammensetzungen zur Einleitung antigenspezifischer immunologischer Toleranz durch orale Immunisierung
US9732131B2 (en) 2006-02-27 2017-08-15 Calviri, Inc. Identification and use of novopeptides for the treatment of cancer
US20110027348A1 (en) 2007-08-27 2011-02-03 Janos Feher Composition and method inhibiting inflammation
CN110996970A (zh) 2017-06-02 2020-04-10 亚利桑那州立大学董事会 创建个性化癌症疫苗的方法
WO2019055618A1 (en) 2017-09-15 2019-03-21 Arizona Board Of Regents On Behalf Of Arizona State University METHODS OF CLASSIFYING RESPONSES TO ANTICANCER IMMUNOTHERAPY
KR102741244B1 (ko) * 2017-12-19 2024-12-11 인터내셔널 엔＆에이치 덴마크 에이피에스 인지 및 정신 건강을 위한 프로바이오틱스
WO2021067550A1 (en) 2019-10-02 2021-04-08 Arizona Board Of Regents On Behalf Of Arizona State University Methods and compositions for identifying neoantigens for use in treating and preventing cancer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH639280A5 (de) * 1977-12-23 1983-11-15 Solco Basel Ag Verfahren zur herstellung einer vakzine gegen das trichomonas-syndrom.
DE19522472C2 (de) * 1995-06-21 1998-07-02 Eugen Baumgaertner Herstellungsverfahren eines Fermentationsproduktes zur Behandlung von Prostataleiden
GB2338245B (en) * 1997-08-21 2001-11-21 New Zealand Dairy Board Immunity enhancing lactic acid bacteria
IT1298918B1 (it) * 1998-02-20 2000-02-07 Mendes Srl Uso di batteri dotati di arginina deiminasi per indurre apoptosi e/o ridurre una reazione infiammatoria e composizioni farmaceutiche
IT1306716B1 (it) * 1999-06-21 2001-10-02 Mendes S U R L Associazione di batteri lattici e suo uso per la prevenzione e/o iltrattamento terapeutico di infezioni e di stati infiammatori.

Also Published As

Publication number Publication date
SI20960B (sl) 2011-01-31
PL201804B1 (pl) 2009-05-29
HU227086B1 (en) 2010-06-28
WO2001037862A2 (en) 2001-05-31
US20180161414A1 (en) 2018-06-14
YU37402A (sh) 2005-06-10
EP1272216A2 (de) 2003-01-08
EA200200602A1 (ru) 2002-10-31
CA2394843C (en) 2011-01-18
RS51201B (sr) 2010-12-31
US20160051657A1 (en) 2016-02-25
SK7382002A3 (en) 2002-11-06
UA78673C2 (en) 2007-04-25
CA2394843A1 (en) 2001-05-31
US20110243990A1 (en) 2011-10-06
HUP9904408D0 (en) 2000-01-28
DK1272216T3 (da) 2010-09-27
EP1272216B1 (de) 2010-06-09
AU779214B2 (en) 2005-01-13
WO2001037862A3 (en) 2001-11-22
IL149779A (en) 2009-05-04
PL355886A1 (en) 2004-05-31
ES2348591T3 (es) 2010-12-09
DE60044539D1 (de) 2010-07-22
SI20960A (sl) 2003-02-28
HUP9904408A2 (hu) 2002-03-28
RO122760B1 (ro) 2010-01-29
SK288132B6 (sk) 2013-10-02
EA005198B1 (ru) 2004-12-30
US9056073B2 (en) 2015-06-16
IL149779A0 (en) 2002-11-10
US20080175865A1 (en) 2008-07-24
CZ20021771A3 (cs) 2002-11-13
AU1874101A (en) 2001-06-04
PT1272216E (pt) 2010-09-14
CZ302662B6 (cs) 2011-08-24

Similar Documents

Publication Publication Date Title
DE69718150D1 (de) Peptid-immunogene zur schutzimpfung gegen und behandlung von allergien
DE69735995D1 (de) Oligoepitop-peptid des prostata-spezifischen antigens
EP1231914A4 (de) Nordihydroguaiaretinsäurederivate zur behandlung von tumoren
DE69703689D1 (de) Therapeutische anwendungen von bpi-protein-produkten zur behandlung von humaner meningococcämia
DE69815310D1 (de) Zubereitungen zur tumorbehandlung enthaltend hai-knorpelextrakte und antineoplastische mittel
ATE306938T1 (de) Verwendung von cpg als adjuvans für hivimpstoff
DE69533673D1 (de) Behandlung und prävention von helicobacter-infektionen
ATE253934T1 (de) Verwendung eines angiogenen faktors zur behandlung von mikrovaskulären angiopathien
ATE470452T1 (de) Impfstoff enthaltend lactobacilli zur behandlung von entzündungen der prostata und gutartigen prostata-hyperplasien
NO984760L (no) Anvendelse av en osmolytt ved behandling av effekter forÕrsaket av en infeksjon, en inflammasjon eller en immundysfunksjon
DE69924483D1 (de) Kombinationstherapie zur behandlung von tumoren
ATE304365T1 (de) Verwendung von humanen prostatazellinien zur behandlung von prostatakrebs
ATE283920T1 (de) Verfahren zur immunisierung und behandlung von h. pylori infektion
DE60142786D1 (de) Zusammensetzungen und methoden zur behandlung von candidosen
NO20030137L (no) Fremgangsmåte for behandling av ustabil angina pectoris
DK1162985T3 (da) Matrixproteinsammensætninger til induktion af apoptose
DE60109594D1 (de) R-eliprodil zur behandlung von glaucoma
EP1143981A4 (de) Behandlung und vorbeugung von hiv- und anderen virus infektionen
ATE459372T1 (de) Vorbeugung und behandlung von p. gingivalis infektion
UA36485A (uk) Спосіб лікування генералізованого пародонтиту
FR2812549B1 (fr) Associations dalfopristine/quinupristine avec le cefpirome
UA32281A (uk) Засіб "регенерин" для зовнішнього лікування гнійних ран і трофічних виразок
UA32314A (uk) Спосіб лікування некротичного панкреатиту
UA32651C2 (uk) Спосіб напіввідкритої лапаростомії

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1272216

Country of ref document: EP